Professor Chris Packard reviews the latest evidence showing that triglyceride-rich lipoproteins and their remnants can initiate and progress atherogenesis, and discusses the potential of novel and existing agents in regulating remnant lipoproteins.
Please login or create a FREE account to view this content
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.